MedinCell S.A.
EPA:MEDCL.PA
16.3 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.032 | 9.889 | 4.09 | 8.186 | 2.852 | 1.443 | 6.438 | 8.533 | 8.232 |
| Cost of Revenue
| -0.128 | -3.766 | -4.248 | 1.451 | 0.969 | 1.009 | 0.218 | 0.885 | 0.332 |
| Gross Profit
| 9.16 | 13.655 | 8.338 | 6.735 | 1.883 | 0.434 | 6.22 | 7.648 | 7.9 |
| Gross Profit Ratio
| 1.014 | 1.381 | 2.039 | 0.823 | 0.66 | 0.301 | 0.966 | 0.896 | 0.96 |
| Reseach & Development Expenses
| 21.076 | 26.666 | 22.44 | 18.505 | 16.204 | 11.975 | 8.846 | 7.551 | 5.958 |
| General & Administrative Expenses
| 0 | 7.128 | 6.214 | 5.641 | 5.599 | 4.899 | 4.246 | 2.868 | 2.155 |
| Selling & Marketing Expenses
| 0 | 2.588 | 2.272 | 1.797 | 2.362 | 2.676 | 1.888 | 1.382 | 0.752 |
| SG&A
| 11.809 | 9.395 | 8.28 | 7.352 | 7.76 | 7.575 | 6.098 | 4.241 | 2.909 |
| Other Expenses
| 0 | 0 | 0 | -0.02 | -0.099 | 15.949 | 4.674 | 2.838 | 1.853 |
| Operating Expenses
| 32.885 | 36.061 | 30.72 | 25.877 | 24.063 | 15.949 | 13.52 | 10.389 | 7.811 |
| Operating Income
| -23.853 | -27.837 | -28.146 | -19.031 | -22.467 | -15.516 | -7.378 | -3.589 | 0.421 |
| Operating Income Ratio
| -2.641 | -2.815 | -6.882 | -2.325 | -7.878 | -10.753 | -1.146 | -0.421 | 0.051 |
| Total Other Income Expenses Net
| -4.01 | -7.939 | -0.907 | -3.544 | -2.123 | -4.203 | -1.915 | -2.146 | -0.091 |
| Income Before Tax
| -27.863 | -35.776 | -29.053 | -22.575 | -24.59 | -19.71 | -9.215 | -4.887 | 0.33 |
| Income Before Tax Ratio
| -3.085 | -3.618 | -7.103 | -2.758 | -8.622 | -13.659 | -1.431 | -0.573 | 0.04 |
| Income Tax Expense
| -2.825 | -3.766 | -4.247 | -3.589 | -0.675 | -0.028 | 0.36 | -1.35 | -0.255 |
| Net Income
| -25.038 | -32.01 | -24.806 | -18.986 | -23.915 | -19.687 | -9.571 | -3.561 | 0.622 |
| Net Income Ratio
| -2.772 | -3.237 | -6.065 | -2.319 | -8.385 | -13.643 | -1.487 | -0.417 | 0.076 |
| EPS
| -0.88 | -1.27 | -1 | -0.86 | -1.19 | -1.14 | -0.66 | -0.25 | 0.043 |
| EPS Diluted
| -0.88 | -1.27 | -1 | -0.86 | -1.19 | -1.14 | -0.66 | -0.25 | 0.043 |
| EBITDA
| -18.614 | -26.172 | -26.63 | -17.691 | -21.211 | -15.221 | -6.406 | -2.185 | 0.788 |
| EBITDA Ratio
| -2.061 | -2.647 | -6.511 | -2.161 | -7.437 | -10.548 | -0.995 | -0.256 | 0.096 |